News
New treatment could spare early-stage rectal cancer patients life-altering side effects
A new less invasive treatment is safer than standard major surgery for early-stage rectal cancer, giving patients a better quality of life with fewer life-altering side effects, a pilot study shows.
COVID and Me Vaccine Stories
Professor Sue Pavitt has co-produced 'COVID and Me Vaccine Stories' in partnership with the National Institute of Health Research (NIHR) and the Theatre of Debate.
Medical record linkage study discovers that patients receiving low dose steroid are at an increased risk of cardiovascular disease
Medication used to treat a range of inflammatory diseases may be less safe than previously thought.
Using research power to tackle global issues
The University of Leeds has secured part of a new £147 million research initiative to work with developing nations on the world's biggest challenges.
Genetic study reveals pre-eclampsia risk factors
A large international study has revealed that the genetic risk of pre-eclampsia, a potentially dangerous condition in pregnancy, is related to blood pressure and body mass index (BMI).